Medpace Holdings, Inc.

NASDAQ:MEDP

Medical - Diagnostics & Research

Healthcare
$646.87 -0.98%

-$4.51 today

Market cap
$18.09B
Beta
1.18
P/E (TTM)
28.2
EPS (TTM)
$16.19
52W Low $301.90High $628.92

Volume 0.21M

Average 0.36M

MEDP Pre-Tax Margin

Income before tax as a percentage of revenue.

Medpace Holdings, Inc.NASDAQ: MEDP

Pre-Tax Margin · Q3 FY2026 · quarter ended Sep 2026

Pre-tax margin widens to 23.9%

Pre-tax margin was 23.9% in Q3 FY2026, up 2.2 pp from a year earlier. On a trailing-twelve-month basis it was 22.1%, up 0.1 pp year over year. Over 3 fiscal years it widened by 2.1 pp.

Context

  • Pre-tax margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
23.9%+2.4 pp QoQ
Last fiscal yearDec 2025
21.4%-1.1 pp YoY
LTMSep 2026
22.1%+0.1 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+2.2 pp——
1 year-1.1 pp——
3 years+2.1 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
21.4%
Year-over-year change
-1.1pp

Pre-Tax Margin vs competitors

How MEDP compares with its peers on the latest reported figures

  • MEDP's LTM Sep 2026 pre-tax margin of 22.1% is the highest of the 5 companies compared; the peer median is 1.1%.
  • Its year-over-year change of +0.1 pp is the 2nd highest of 5, against a peer median of -2.2 pp.
  • Over three fiscal years its change of +2.1 pp compares with a peer median of -11.2 pp.
MEDP Competitors Peer median
Pre-Tax Margin for MEDP and competitors
Company Period LTM level YoY 3-year change
MEDPMedpace Holdings, Inc.LTM Sep 202622.1% +0.1 pp+2.1 pp
IQVIQVIA Holdings Inc.LTM Jun 20269.5% -0.3 pp+0.5 pp
ICLRICON Public Limited CompanyLTM Jun 20265.1% -5.1 pp-4.2 pp
FTREFortrea Holdings Inc.LTM Jun 2026-2.9% +34.8 pp-42.7 pp
CRLCharles River Laboratories International, Inc.LTM Jun 2026-4.6% -4.1 pp-18.1 pp
Peer median (excluding MEDP) 1.1%-2.2 pp-11.2 pp

Competitors are the stored peer set for MEDP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.14B1.46B1.89B2.11B2.53B
Cost of Revenue814.22M1.03B1.36B1.45B1.77B
Gross Profit328.16M432.44M524.51M656.31M760.62M
Gross Margin28.7%29.6%27.8%31.1%30.1%
Research & Development00000
Selling, General & Admin108.42M131.4M161.35M180.18M197.56M
Operating Expenses129.54M153.74M187.68M209.44M225.68M
Depreciation & Amortization21.12M22.34M26.33M29.25M28.12M
EBITDA223.08M308.11M362.5M505.17M570.5M
EBITDA Margin19.5%21.1%19.2%24.0%22.5%
Operating Income198.62M278.7M336.83M446.87M534.94M
Operating Margin17.4%19.1%17.9%21.2%21.1%
Interest Income00025M0
Interest Expense105K2.91M488K00
Other Income / Expenses3.24M4.16M(1.14M)29.05M7.44M
Income Before Tax201.85M282.86M335.68M475.92M542.38M
Pre-Tax Margin17.7%19.4%17.8%22.6%21.4%
Income Tax Expense20M37.49M52.87M71.54M91.25M
Net Income181.85M245.37M282.81M404.39M451.12M
Net Margin15.9%16.8%15.0%19.2%17.8%
EPS (Basic)5.067.579.2013.0615.64
EPS (Diluted)4.817.288.8812.6315.28
Weighted Avg Shares35.86M32.39M30.72M30.96M28.85M
Weighted Avg Shares (Diluted)37.7M33.67M31.84M32.01M29.53M

Medpace Holdings, Inc.

NASDAQ:MEDP

Intrinsic Alpha fair value

Locked

Current Price

$646.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.